Status:
UNKNOWN
Impact of Severe Acute Respiratory Syndrome (SARS-CoV-2/COVID-19) Related Pneumonia on Lung Function and Structure.
Lead Sponsor:
National Institute for Tuberculosis and Lung Diseases, Poland
Collaborating Sponsors:
Medical University of Warsaw
Conditions:
Covid19
SARS-CoV Infection
Eligibility:
All Genders
18-100 years
Brief Summary
Prospective study in a group of patients with COVID-19 pneumonia.
Detailed Description
Objective: Assessment of pulmonary and heart dysfunction, fibrosis-related markers and antibodies as well as the search for risk factors for an unfavorable course and possible complications in patien...
Eligibility Criteria
Inclusion
- Confirmed SARS-CoV-2 infection with pneumonia hospitalized
- Two negative PCR results of a swab from the respiratory tract in succession, including the last one taken no later than 3 days before the planned lung function tests (1st visit).
Exclusion
- Lack of patient consent,
- Present contraindications for lung function tests
- Inability to perform correctly lung function measurements
Key Trial Info
Start Date :
August 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04916834
Start Date
August 30 2020
End Date
November 30 2024
Last Update
February 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute for Tuberculosis and Lung Diseases
Warsaw, Masovian Voivodeship, Poland, 01-138